Literature DB >> 6319408

Simian virus 40-infected, interferon-treated cells contain 2',5'-oligoadenylates which do not activate cleavage of RNA.

C L Hersh, R E Brown, W K Roberts, E A Swyryd, I M Kerr, G R Stark.   

Abstract

2',5'-oligoadenylates can be assayed sensitively in cell extracts by use of an antiserum having maximum specificity for any compound containing the moiety -pA2'pA2'pA-. These compounds reached high concentrations (25-2000 nM) in monkey CV-1 cells after infection with simian virus 40 (SV40) and treatment with human leukocyte interferon. The levels were highest late in infection and increased in parallel with the accumulation of SV40 late messenger RNAs. Alone, neither interferon nor SV40 caused the 2',5'-oligoadenylate concentrations to increase above the levels present in untreated CV-1 cells, 3 nM or less. Analyses by high performance liquid chromatography revealed little or no (p)pp(A2'p)2A or (p)pp(A2'p)3A, and the extracts showed only very low activity in functional assays with ppp(A2'p)nA-dependent nucleases, equivalent to 3 nM ppp(A2'p)3A or less. Some of the 2',5'-oligoadenylates eluted in the positions of the nonphosphorylated "cores," (A2'p)nA, and a substantial fraction was found in several peaks intermediate between ppp(A2'p)3A and cores. The positions of most of these peaks did not change when digestion with alkaline phosphatase was performed before chromatography, indicating that most of the 2',5'-oligoadenylates lack exposed phosphate groups. In contrast to the effects of infection with SV40, addition of poly(I) X poly(C) to interferon-treated CV-1 cells led to accumulation of high levels (up to 3000 nM) of 2',5'-oligoadenylate-5'-di- or triphosphates capable of activating the ppp(A2'p)nA-dependent ribonuclease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319408

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Suppressing PARylation by 2',5'-oligoadenylate synthetase 1 inhibits DNA damage-induced cell death.

Authors:  Anna A Kondratova; HyeonJoo Cheon; Beihua Dong; Elise G Holvey-Bates; Metis Hasipek; Irina Taran; Christina Gaughan; Babal K Jha; Robert H Silverman; George R Stark
Journal:  EMBO J       Date:  2020-04-23       Impact factor: 11.598

Review 2.  Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.

Authors:  Robert H Silverman
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

3.  Immune gene expression in swine macrophages expressing the Torque Teno Sus Virus1 (TTSuV1) ORF-1 and 2 proteins.

Authors:  Pankaj Singh; Sheela Ramamoorthy
Journal:  Virus Res       Date:  2016-04-05       Impact factor: 3.303

Review 4.  Regulation of cell proliferation and differentiation by interferons.

Authors:  M J Clemens; M A McNurlan
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

5.  Recognition of 2',5'-linked oligoadenylates by human ribonuclease L: molecular dynamics study.

Authors:  Kamil Maláč; Ivan Barvík
Journal:  J Mol Model       Date:  2014-03-16       Impact factor: 1.810

6.  Modulation of ppp(A2'p)nA-dependent RNase by a temperature-sensitive mutant of vaccinia virus.

Authors:  R J Cohrs; R C Condit; R F Pacha; C L Thompson; O K Sharma
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

Review 7.  Viral phosphodiesterases that antagonize double-stranded RNA signaling to RNase L by degrading 2-5A.

Authors:  Robert H Silverman; Susan R Weiss
Journal:  J Interferon Cytokine Res       Date:  2014-06       Impact factor: 2.607

Review 8.  Diverse functions of RNase L and implications in pathology.

Authors:  Catherine Bisbal; Robert H Silverman
Journal:  Biochimie       Date:  2007-02-20       Impact factor: 4.079

9.  Lack of strong anti-viral immune gene stimulation in Torque Teno Sus Virus1 infected macrophage cells.

Authors:  P Singh; S Ramamoorthy
Journal:  Virology       Date:  2016-05-11       Impact factor: 3.616

10.  Novel 2',5'-oligoadenylates synthesized in interferon-treated, vaccinia virus-infected cells.

Authors:  A P Rice; S M Kerr; W K Roberts; R E Brown; I M Kerr
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.